INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2011

In patients with subclinical hypothyroidism, 16 mg soy phytoestrogens increased risk of overt hypothyroidism but reduced blood pressure, HOMA-IR, and hsCRP.

Sixty patients with subclinical hypothyroidism were randomly assigned to 8 weeks of 30 g soy protein with 2 mg phytoestrogens or 16 mg phytoestrogens, followed by an 8-week washout and crossover. Six female patients progressed to overt hypothyroidism after the 16-mg supplementation (standardized rate ratio 3.6; 95% CI, 1.9, 6.2). In addition, 16 mg phytoestrogens decreased systolic and diastolic blood pressure, insulin resistance (HOMA-IR: 3.5 ± 0.09 vs. 2.6 ± 0.08; P < 0.02), and hsCRP (4.9 ± 0.04 vs. 3.9 ± 0.03; P < 0.01), while lipid profiles remained unchanged.

Study type
Randomized, double-blind, crossover study
Who was studied
60 patients with subclinical hypothyroidism
What was measured
Progression to overt hypothyroidism, blood pressure, insulin resistance, lipids, and hsCRP

THE PAPER

The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind, crossover study.

Sathyapalan T, Manuchehri AM, Thatcher NJ, Rigby AS, Chapman T, Kilpatrick ES, Atkin SL. J Clin Endocrinol Metab, 2011.

PubMed 21325465 ↗DOI 10.1210/jc.2010-2255 ↗

Heart & arteriesDiabetes & blood sugarBlood pressureOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.